Osteoarthritis affects an estimated 20-25% of dogs, causing chronic pain that significantly reduces quality of life and is frequently under-recognised and under-treated in veterinary practice.
Canine osteoarthritis is a major welfare issue precisely because it is so common and so frequently undertreated. Dogs in chronic pain often become withdrawn, less playful, and reluctant to exercise — behaviours owners may attribute to ageing rather than pain. The insidious onset means dogs may suffer for months or years before appropriate analgesia is initiated. Anti-NGF monoclonal antibodies (such as bedinvetmab) represent a significant advance — monthly injections provide sustained pain relief without the gastrointestinal side-effects of NSAIDs. Physiotherapy and hydrotherapy strengthen muscles supporting arthritic joints, while environmental modifications — ramps, orthopedic beds, non-slip surfaces — reduce daily pain triggers. Early intervention prevents disease progression.